Lijffijt, Marijn
Murphy, Nicholas http://orcid.org/0000-0003-1805-3082
Iqbal, Sidra
Green, Charles E.
Iqbal, Tabish
Chang, Lee C.
Haile, Colin N.
Hirsch, Lorna C.
Ramakrishnan, Nithya
Fall, Dylan A.
Swann, Alan C.
Al Jurdi, Rayan K.
Mathew, Sanjay J. http://orcid.org/0000-0002-2715-6641
Funding for this research was provided by:
U.S. Department of Veterans Affairs (CX-001205-01AI)
Article History
Received: 13 August 2021
Revised: 25 October 2021
Accepted: 8 November 2021
First Online: 27 November 2021
Competing interests
: SJM has served as a consultant to Allergan, Alkermes, Axsome Therapeutics, BioXcel Therapeutics, Clexio Biosciences, Eleusis, EMA Wellness, Engrail Therapeutics, Greenwich Biosciences, Intra-Cellular Therapies, Janssen, Levo Therapeutics, Perception Neurosciences, Neurocrine, Relmada Therapeutics, Sage Therapeutics, Seelos Therapeutics, and Signant Health. He has served as an investigator for studies funded by Janssen, Merck, NeuroRx, and Sage Therapeutics, and has received research support from Biohaven Pharmaceuticals and VistaGen Therapeutics. RKA has served on the Janssen advisory and speaker board. ML has served as principal investigator for trials funded by NeuroRx and VistaGen Therapeutics. The remaining authors have nothing to disclose.